Your browser doesn't support javascript.
loading
Levodopa dose maintenance or reduction in patients with Parkinson's disease transitioning to levodopa/carbidopa/entacapone.
Park, Jongkyu; Kim, Younsoo; Youn, Jinyoung; Lee, Phil H; Sohn, Young H; Koh, Seoung B; Lee, Jee-Young; Baik, Jong S; Cho, Jin W.
Afiliação
  • Park J; Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Kim Y; Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Youn J; Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Lee PH; Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.
  • Sohn YH; Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.
  • Koh SB; Department of Neurology, Korea University College of Medicine at Guro Hospital, Seoul, Korea.
  • Lee JY; Department of Neurology, Seoul National University, Seoul Metropolitan Government Boramae Medical Center, Seoul, Korea.
  • Baik JS; Department of Neurology, Sanggye Paik Hospital, Inje University, Seoul, Korea.
  • Cho JW; Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Neurol India ; 65(4): 746-751, 2017.
Article em En | MEDLINE | ID: mdl-28681744

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Levodopa / Antiparkinsonianos Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Levodopa / Antiparkinsonianos Idioma: En Ano de publicação: 2017 Tipo de documento: Article